Sale!

UCP2 Gene Hyperinsulinism UCP2 Related Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The UCP2 Gene Hyperinsulinism test, available at DNA Labs UAE for a cost of 4400 AED, is a specialized genetic test designed to detect mutations in the UCP2 gene, which have been associated with hyperinsulinism. Hyperinsulinism is a condition characterized by the excessive production of insulin by the pancreas, leading to low blood sugar levels (hypoglycemia). The UCP2 gene plays a crucial role in regulating the secretion of insulin and energy metabolism within the body’s cells.

This test is particularly important for individuals who may have a family history of hyperinsulinism or who exhibit symptoms of the condition, such as frequent episodes of hypoglycemia, seizures, and excessive hunger. By identifying specific genetic mutations in the UCP2 gene, healthcare providers can offer a more accurate diagnosis, tailor treatment plans to manage symptoms effectively, and provide genetic counseling to affected families.

Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves collecting a small sample of the patient’s blood or saliva. The sample is then analyzed using advanced genetic sequencing techniques to identify any mutations in the UCP2 gene. Results from this test can provide valuable insights into the genetic basis of hyperinsulinism and contribute to the development of personalized medicine approaches for managing the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

UCP2 Gene Hyperinsulinism UCP2 related Genetic Test

Test Details

UCP2 gene hyperinsulinism refers to a genetic condition characterized by mutations in the UCP2 gene, which is responsible for producing a protein called uncoupling protein 2. This protein plays a role in regulating insulin secretion in the pancreas. Mutations in the UCP2 gene can lead to abnormal insulin secretion, resulting in hyperinsulinism. Hyperinsulinism is a condition characterized by excessive production and release of insulin, which can lead to low blood sugar levels (hypoglycemia).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA and identify genetic mutations or variations. In the case of UCP2-related hyperinsulinism, NGS genetic testing can be used to identify specific mutations in the UCP2 gene that may be causing the condition. By identifying the specific genetic mutations involved, NGS genetic testing can help in diagnosing UCP2 gene hyperinsulinism and provide important information for personalized treatment and management of the condition. It can also be used for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations.

Test Name: UCP2 Gene Hyperinsulinism UCP2 related Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for UCP2 Gene Hyperinsulinism, UCP2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinism, UCP2 related.
Test Name UCP2 Gene Hyperinsulinism UCP2 related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for UCP2 Gene Hyperinsulinism, UCP2 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinism, UCP2 related
Test Details

UCP2 gene hyperinsulinism refers to a genetic condition characterized by mutations in the UCP2 gene, which is responsible for producing a protein called uncoupling protein 2. This protein plays a role in regulating insulin secretion in the pancreas.

Mutations in the UCP2 gene can lead to abnormal insulin secretion, resulting in hyperinsulinism. Hyperinsulinism is a condition characterized by excessive production and release of insulin, which can lead to low blood sugar levels (hypoglycemia).

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA and identify genetic mutations or variations. In the case of UCP2-related hyperinsulinism, NGS genetic testing can be used to identify specific mutations in the UCP2 gene that may be causing the condition.

By identifying the specific genetic mutations involved, NGS genetic testing can help in diagnosing UCP2 gene hyperinsulinism and provide important information for personalized treatment and management of the condition. It can also be used for genetic counseling and family planning purposes, as it can help determine the risk of passing on the condition to future generations.